Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02653599 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes
A Phase 2 study, sponsored by vTv Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 174
- Enrollment target
NCT02653599 is a Phase 2 study that has completed, run by vTv Therapeutics. The registered enrollment target is 174 participants.
The verdict
NCT02653599, a Phase 2 study, has completed, sponsored by vTv Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 174 participants
- Enrollment target
Study Summary
This trial is a multi-center, randomized, double-blind, placebo-controlled parallel group, Phase 2 study in subjects with Type 2 diabetes mellitus on a stable dose of metformin to evaluate the safety and efficacy of TTP273 versus placebo glucose control and body weight following administration for 3 months.
Interventions
- DRUG Placebo
- DRUG TTP273
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02653599
The ClinicalTrials.gov registry entry for NCT02653599 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is vTv Therapeutics, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02653599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02653599 about?
NCT02653599 is a clinical study titled "A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes". This trial is a multi-center, randomized, double-blind, placebo-controlled parallel group, Phase 2 study in subjects with Type 2 diabetes mellitus on a stable dose of metformin to evaluate the safety and efficacy of TTP273 versus placebo glucose control and body weight following administration for 3...
What is the current status of trial NCT02653599?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 174 participants. The study started on 2015-12. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02653599?
The interventions under investigation include: Placebo (DRUG), TTP273 (DRUG).
Who is sponsoring clinical trial NCT02653599?
This trial is sponsored by vTv Therapeutics, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.